Gemcitabine/Dexamethasone/Cisplatin vs Cytarabine/Dexamethasone/Cisplatin for Relapsed or Refractory Aggressive-Histology Lymphoma: Cost-Utility Analysis of NCIC CTG LY.12

Matthew C. Cheung; Annette E. Hay; Michael Crump; Kevin R. Imrie; Yuyao Song; Shazia Hassan; Nancy Risebrough; Jonathan Sussman; Stephen Couban; David Macdonald; Vishal Kukreti; C. Tom Kouroukis; Tara Baetz; David Szwajcer; Pierre Desjardins; Lois Shepherd; Ralph M. Meyer; Al Le; Bingshu E. Chen; Nicole Mittmann

doi:10.1093/jnci/djv106

Gemcitabine/Dexamethasone/Cisplatin vs Cytarabine/Dexamethasone/Cisplatin for Relapsed or Refractory Aggressive-Histology Lymphoma: Cost-Utility Analysis of NCIC CTG LY.12

Matthew C. Cheung, Annette E. Hay, Michael Crump, Kevin R. Imrie, Yuyao Song, Shazia Hassan, Nancy Risebrough, Jonathan Sussman, Stephen Couban, David Macdonald, Vishal Kukreti, C. Tom Kouroukis, Tara Baetz, David Szwajcer, Pierre Desjardins, Lois Shepherd, Ralph M. Meyer, Al Le, Bingshu E. Chen, Nicole Mittmann

Pharmacology, Toxicology and Pharmaceutics

科研成果: 期刊稿件 › 文章 › 同行评审

20 引用（Scopus）

源语言	英语
期刊	Journal of the National Cancer Institute
卷	107
期	7
DOI	https://doi.org/10.1093/jnci/djv106
出版状态	已出版 - 7月 1 2015

!!!ASJC Scopus Subject Areas

肿瘤学
癌症研究

联合国可持续发展目标

此成果有助于实现下列可持续发展目标：

访问文件

10.1093/jnci/djv106

其它文件与链接

引用此

Cheung, M. C., Hay, A. E., Crump, M., Imrie, K. R., Song, Y., Hassan, S., Risebrough, N., Sussman, J., Couban, S., Macdonald, D., Kukreti, V., Kouroukis, C. T., Baetz, T., Szwajcer, D., Desjardins, P., Shepherd, L., Meyer, R. M., Le, A., Chen, B. E., & Mittmann, N. (2015). Gemcitabine/Dexamethasone/Cisplatin vs Cytarabine/Dexamethasone/Cisplatin for Relapsed or Refractory Aggressive-Histology Lymphoma: Cost-Utility Analysis of NCIC CTG LY.12. Journal of the National Cancer Institute, 107(7). https://doi.org/10.1093/jnci/djv106

Cheung, MC, Hay, AE, Crump, M, Imrie, KR, Song, Y, Hassan, S, Risebrough, N, Sussman, J, Couban, S, Macdonald, D, Kukreti, V, Kouroukis, CT, Baetz, T, Szwajcer, D, Desjardins, P, Shepherd, L, Meyer, RM, Le, A, Chen, BE & Mittmann, N 2015, 'Gemcitabine/Dexamethasone/Cisplatin vs Cytarabine/Dexamethasone/Cisplatin for Relapsed or Refractory Aggressive-Histology Lymphoma: Cost-Utility Analysis of NCIC CTG LY.12', Journal of the National Cancer Institute, 卷 107, 号码 7. https://doi.org/10.1093/jnci/djv106

@article{d1019ef4f4874892ab48dd8824be0fb3,

title = "Gemcitabine/Dexamethasone/Cisplatin vs Cytarabine/Dexamethasone/Cisplatin for Relapsed or Refractory Aggressive-Histology Lymphoma: Cost-Utility Analysis of NCIC CTG LY.12",

author = "Cheung, {Matthew C.} and Hay, {Annette E.} and Michael Crump and Imrie, {Kevin R.} and Yuyao Song and Shazia Hassan and Nancy Risebrough and Jonathan Sussman and Stephen Couban and David Macdonald and Vishal Kukreti and Kouroukis, {C. Tom} and Tara Baetz and David Szwajcer and Pierre Desjardins and Lois Shepherd and Meyer, {Ralph M.} and Al Le and Chen, {Bingshu E.} and Nicole Mittmann",

year = "2015",

month = jul,

day = "1",

doi = "10.1093/jnci/djv106",

language = "English",

volume = "107",

journal = "Journal of the National Cancer Institute",

issn = "0027-8874",

publisher = "Oxford University Press",

number = "7",

}

TY - JOUR

T1 - Gemcitabine/Dexamethasone/Cisplatin vs Cytarabine/Dexamethasone/Cisplatin for Relapsed or Refractory Aggressive-Histology Lymphoma

T2 - Cost-Utility Analysis of NCIC CTG LY.12

AU - Cheung, Matthew C.

AU - Hay, Annette E.

AU - Crump, Michael

AU - Imrie, Kevin R.

AU - Song, Yuyao

AU - Hassan, Shazia

AU - Risebrough, Nancy

AU - Sussman, Jonathan

AU - Couban, Stephen

AU - Macdonald, David

AU - Kukreti, Vishal

AU - Kouroukis, C. Tom

AU - Baetz, Tara

AU - Szwajcer, David

AU - Desjardins, Pierre

AU - Shepherd, Lois

AU - Meyer, Ralph M.

AU - Le, Al

AU - Chen, Bingshu E.

AU - Mittmann, Nicole

PY - 2015/7/1

Y1 - 2015/7/1

UR - http://www.scopus.com/inward/record.url?scp=84938099548&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84938099548&partnerID=8YFLogxK

U2 - 10.1093/jnci/djv106

DO - 10.1093/jnci/djv106

M3 - Article

C2 - 25868579

AN - SCOPUS:84938099548

SN - 0027-8874

VL - 107

JO - Journal of the National Cancer Institute

JF - Journal of the National Cancer Institute

IS - 7

ER -

Gemcitabine/Dexamethasone/Cisplatin vs Cytarabine/Dexamethasone/Cisplatin for Relapsed or Refractory Aggressive-Histology Lymphoma: Cost-Utility Analysis of NCIC CTG LY.12

!!!ASJC Scopus Subject Areas

联合国可持续发展目标

访问文件

其它文件与链接

指纹

引用此